Maximus (NYSE:MMS) Rating Lowered to “Strong Sell” at Zacks Research

Maximus (NYSE:MMS) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports.

Other analysts have also recently issued reports about the stock. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

Maximus Stock Up 0.5%

Shares of MMS stock opened at $54.45 on Tuesday. The stock’s 50 day simple moving average is $58.24 and its 200 day simple moving average is $66.33. Maximus has a twelve month low of $52.73 and a twelve month high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The company has a market capitalization of $2.85 billion, a price-to-earnings ratio of 8.04 and a beta of 0.59.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the prior year, the business earned $2.16 earnings per share. The company’s revenue was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, research analysts predict that Maximus will post 8.01 EPS for the current year.

Hedge Funds Weigh In On Maximus

Several institutional investors and hedge funds have recently modified their holdings of MMS. Farther Finance Advisors LLC increased its stake in Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after purchasing an additional 116 shares in the last quarter. Advisory Services Network LLC bought a new position in Maximus in the third quarter valued at approximately $32,000. Northwestern Mutual Wealth Management Co. lifted its stake in Maximus by 225.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after buying an additional 304 shares in the last quarter. Canada Pension Plan Investment Board acquired a new position in shares of Maximus in the second quarter valued at approximately $35,000. Finally, Danske Bank A S acquired a new position in shares of Maximus in the third quarter valued at approximately $55,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.